EXTON,
Pa., Oct. 22, 2024 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced participation in the 2024 PDA Universe of Pre-Filled
Syringes and Injection Devices Conference in Phoenix, AZ to showcase its leadership
and expertise on industry challenges and trends in packaging and
containment.
"With the rise of biologic drugs, injectables are the fastest
growing drug segment today, bringing with it new challenges of
complex molecules and treatment requirements," says Atul Patel, Vice President, Delivery Devices at
West. "As the market leader, West continues to adapt and expand the
performance of high-quality drug delivery packaging and devices to
meet the changing needs of patients, regulators, and industry
partners."
At this year's PDA, West will be sharing insights through
various posters and a presentation on how leveraging primary
container and device platforms can reduce risk and accelerate
time-to-market for combination products.
Featured Speaking Session:
Title: Enabling High-Volume Drug Delivery with a Platform
Approach
Speaker: Gurmeet Singh, Senior
Director, Business Development
Date and Time: October 22, 2024,
10:25- 10:35am PST
Featured Posters:
Title: Performance of Pre-Filled Syringe Systems at Low
Temperature
Author: Page McAndrew, Director,
Scientific Communications
Title: Container Closure Integrity Testing Strategy for Drug-led
Combination Products: A Practical Approach
Author: Jen Roark, Technology
Manager, Scientific Affairs
Title: Evaluating Vial Adapter Transfer Devices for
Reconstitution with Pre-Filled Syringes: Using USP (United States
Pharmacopoeia) <382>
Author: Ronan Jenkinson, Manager, Sales Business and
Development, Combination Product and Services
Title: Visual Impairment Affordances Can Benefit All
Users
Author: Lisa Lacouette-Ward, Senior
Specialist, Regulatory Affairs
For more information about the PDA Universe of Pre-Filled
Syringes and Injection Devices Conference, please
visit: PDA Universe of Pre-Filled Syringes and Injection
Devices Conference 2024 | PDA
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With over
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering approximately 43 billion components and
devices each year.
Headquartered in Exton,
Pennsylvania, West in its fiscal year 2023 generated
$2.95 billion in net sales. West is
traded on the New York Stock Exchange (NYSE: WST) and is included
on the Standard & Poor's 500 index. For more information, visit
www.westpharma.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-to-present-on-large-volume-delivery-systems-administration-and-transfer-devices-and-prefillable-syringe-component-expertise-at-the-pda-conference-302282228.html
SOURCE West Pharmaceutical Services, Inc.
